Datapile · Sector

Biotech funding

$7M raised across 1 disclosed Biotech rounds.

Last updated · Jun 13, 2026, 8:23 PM UTC · RSS

Total raised
$6.7M
Rounds
1
Countries
1
1 results
Cumulative USD raised · weekly
Geography · click to filter
Loading map…
Country ›United Kingdom ·1
Sector ›AI|Biotech|ClimateTech|ConsumerTech|Crypto|Cybersecurity|DeepTech|Defense
Round ›Angel|Bridge|Debt|Funding Round|Grant|Growth Equity|IPO|Pre-Series A|Pre-Series A5|Pre-Series B|Pre-Series C|Pre-seed|Private Equity|Private Placement|Seed|Seed Extension|Seed and Follow-on|Seed and Series A|Series A|Series A++|Series A1|Series B|Series C|Series C+|Series D|Series D-2|Series E|Series F|Series G|Series Growth|unknown
DateCompanyAmountRoundSectorCountryLead investors
May 21, 26Imperagen
Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.
$6.7MSeedBiotechUnited KingdomPXN Ventures, IQ Capital, Northern Gritstone
Weekly digest

Get the funding terminal in your inbox.

Filtered to your country and sector. One email per week.

Biotech startup funding · $7M across 1 rounds | Datapile